Cargando…

Palmitate Enhances the Efficacy of Cisplatin and Doxorubicin against Human Endometrial Carcinoma Cells

Endometrial cancer is the most common gynecological cancer worldwide. At present there is no effective screening test for its early detection and no curative treatment for women with advanced-stage or recurrent disease. Overexpression of fatty acid synthase is a common molecular feature of a subgrou...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Zih-Syuan, Huang, Shih-Ming, Wang, Yu-Chi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8744704/ https://www.ncbi.nlm.nih.gov/pubmed/35008502 http://dx.doi.org/10.3390/ijms23010080

Ejemplares similares

Mechanisms of Cisplatin in Combination with Repurposed Drugs against Human Endometrial Carcinoma Cells
por: Lin, Chi-Kang, et al.
Publicado: (2021)

Antitumorigenic Effect of Tramadol and Synergistic Effect With Doxorubicin in Human Breast Cancer Cells
por: Huang, Yi-Hsuan, et al.
Publicado: (2022)

Mitochondrial Dysfunction Involved in the Cytotoxicity of Tramadol in Human Endometrial Carcinoma Cells
por: Liu, Li-Chun, et al.
Publicado: (2022)

Lipocalin 2 Enhances Migration and Resistance against Cisplatin in Endometrial Carcinoma Cells
por: Miyamoto, Tsutomu, et al.
Publicado: (2016)

Efficacy of ifosfamide, dacarbazine, doxorubicin and cisplatin in human sarcoma xenografts.
por: Budach, W., et al.
Publicado: (1994)

Intra-Arterial Chemotherapy with Doxorubicin and Cisplatin Is Effective for Advanced Hepatocellular Cell Carcinoma
por: Ma, Ming-Chun, et al.
Publicado: (2014)

Emetine Synergizes with Cisplatin to Enhance Anti-Cancer Efficacy against Lung Cancer Cells
por: Wu, Ti-Hui, et al.
Publicado: (2019)

The resistance of intracellular mediators to doxorubicin and cisplatin are distinct in 3D and 2D endometrial cancer
por: Chitcholtan, Kenny, et al.
Publicado: (2012)

Non-Steroidal Anti-Inflammatory Drugs Increase Cisplatin, Paclitaxel, and Doxorubicin Efficacy against Human Cervix Cancer Cells
por: Robledo-Cadena, Diana Xochiquetzal, et al.
Publicado: (2020)

Systemic chemotherapy with doxorubicin, cisplatin and capecitabine for metastatic hepatocellular carcinoma
por: Park, Se Hoon, et al.
Publicado: (2006)

Inhibiting WEE1 Augments the Antitumor Efficacy of Cisplatin in Urothelial Carcinoma by Enhancing the DNA Damage Process
por: Su, Yu-Li, et al.
Publicado: (2023)

Aqueous Extract of Solanum nigrum Leaves Induces Autophagy and Enhances Cytotoxicity of Cisplatin, Doxorubicin, Docetaxel, and 5-Fluorouracil in Human Colorectal Carcinoma Cells
por: Tai, Chen-Jei, et al.
Publicado: (2013)

Exploring the Functional Roles of Telomere Maintenance 2 in the Tumorigenesis of Glioblastoma Multiforme and Drug Responsiveness to Temozolomide
por: Feng, Shao-Wei, et al.
Publicado: (2023)

Chloroquine enhances the efficacy of cisplatin by suppressing autophagy in human adrenocortical carcinoma treatment
por: Qin, Liang, et al.
Publicado: (2016)

Efficacy and mechanism of retinyl palmitate against UVB-induced skin photoaging
por: Shu, Peng, et al.
Publicado: (2023)

Mild Hyperthermia Responsive Liposomes for Enhanced In Vitro and In Vivo Anticancer Efficacy of Doxorubicin against Hepatocellular Carcinoma
por: Rahim, Muhammad Abdur, et al.
Publicado: (2021)

Integrated Treatment of Aqueous Extract of Solanum nigrum-Potentiated Cisplatin- and Doxorubicin-Induced Cytotoxicity in Human Hepatocellular Carcinoma Cells
por: Wang, Chien-Kai, et al.
Publicado: (2015)

Cisplatin or Doxorubicin Reduces Cell Viability via the PTPIVA3-JAK2-STAT3 Cascade in Hepatocellular Carcinoma
por: Li, Chao-Jen, et al.
Publicado: (2023)

Intestinal microbial dysbiosis aggravates the progression of Alzheimer’s disease in Drosophila
por: Wu, Shih-Cheng, et al.
Publicado: (2017)

Cisplatin and Doxorubicin Induce Distinct Mechanisms of Ovarian Follicle Loss; Imatinib Provides Selective Protection Only against Cisplatin
por: Morgan, Stephanie, et al.
Publicado: (2013)

Single and combined effects of cisplatin and doxorubicin on the human and mouse ovary in vitro
por: Lopes, Federica, et al.
Publicado: (2019)

The Ethanolic Extract of Taiwanofungus camphoratus (Antrodia camphorata) Induces Cell Cycle Arrest and Enhances Cytotoxicity of Cisplatin and Doxorubicin on Human Hepatocellular Carcinoma Cells
por: Lin, Liang-Tzung, et al.
Publicado: (2015)

An Indirect Comparison of the Efficacy and Safety of Dostarlimab and Doxorubicin for the Treatment of Advanced and Recurrent Endometrial Cancer
por: Mathews, Cara, et al.
Publicado: (2022)

MLH1 enhances the sensitivity of human endometrial carcinoma cells to cisplatin by activating the MLH1/c-Abl apoptosis signaling pathway
por: Li, Yue, et al.
Publicado: (2018)

Effects of a new antioestrogen, idoxifene, on cisplatin- and doxorubicin-sensitive and -resistant human ovarian carcinoma cell lines.
por: Sharp, S. Y., et al.
Publicado: (1994)

PLGA-encapsulated tea polyphenols enhance the chemotherapeutic efficacy of cisplatin against human cancer cells and mice bearing Ehrlich ascites carcinoma
por: Singh, Madhulika, et al.
Publicado: (2015)

Methylsulfonylmethane sensitizes endometrial cancer cells to doxorubicin
por: Kowalska, Karolina, et al.
Publicado: (2020)

In situ Co-Delivery of Doxorubicin and Cisplatin by Injectable Thermosensitive Hydrogels for Enhanced Osteosarcoma Treatment
por: Si, Meng, et al.
Publicado: (2022)

Preparation, characterization, and Co-delivery of cisplatin and doxorubicin-loaded liposomes to enhance anticancer Activities
por: Bahrami Parsa, Mahdi, et al.
Publicado: (2023)

Chloroquine-Enhanced Efficacy of Cisplatin in the Treatment of Hypopharyngeal Carcinoma in Xenograft Mice
por: Zhao, Xing-guo, et al.
Publicado: (2015)

Enhanced therapeutic efficacy of doxorubicin against multidrug-resistant breast cancer with reduced cardiotoxicity
por: Zhang, Tianyu, et al.
Publicado: (2023)

PI3K inhibitor enhances the cytotoxic response to etoposide and cisplatin in a newly established neuroendocrine cervical carcinoma cell line
por: Lai, Zih-Yin, et al.
Publicado: (2017)

Upregulation of CFTR Protects against Palmitate-Induced Endothelial Dysfunction by Enhancing Autophagic Flux
por: Chen, Hongqi, et al.
Publicado: (2020)

Correction to: An Indirect Comparison of the Efficacy and Safety of Dostarlimab and Doxorubicin for the Treatment of Advanced and Recurrent Endometrial Cancer
Publicado: (2022)

Doxorubicin and paclitaxel enhance the antitumor efficacy of vaccines directed against HER 2/neu in a murine mammary carcinoma model
por: Eralp, Yesim, et al.
Publicado: (2004)

PLGA-Encapsulated Tea Polyphenols Enhance The Chemotherapeutic Efficacy Of Cisplatin Against Human Cancer Cells And Mice Bearing Ehrlich Ascites Carcinoma [Retraction]
Publicado: (2019)

Cisplatin/dexrazoxane/doxorubicin: Neutropenia and thrombocytopenia: case report
Publicado: (2020)

Benzyl isothiocyanate (BITC) triggers mitochondria-mediated apoptotic machinery in human cisplatin-resistant oral cancer CAR cells
por: Lee, Chiu-Fang, et al.
Publicado: (2018)

Plumbagin Enhances the Anticancer Efficacy of Cisplatin by Increasing Intracellular ROS in Human Tongue Squamous Cell Carcinoma
por: Xue, Danfeng, et al.
Publicado: (2020)

Aspirin enhances the therapeutic efficacy of cisplatin in oesophageal squamous cell carcinoma by inhibition of putative cancer stem cells
por: Zou, Zhigeng, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_o4cl1r2cncqot9i4hmnvqdc65j